Kolexia
Gagnieu Marie-Claude
Pharmacien
Hôpital Edouard Herriot
Lyon, France
82 Activités
54 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH Leucémie myéloïde chronique BCR-ABL positive Hépatite Hépatite C Hépatite C chronique Leucémies Leucémie myéloïde Maladie de Gilbert Arthrite infectieuse

Industries

MSD
12 collaboration(s)
Dernière en 2022
ViiV Healthcare
6 collaboration(s)
Dernière en 2020
Janssen
3 collaboration(s)
Dernière en 2021
Gilead
1 collaboration(s)
Dernière en 2022

Dernières activités

Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV-1-infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER study).
British journal of clinical pharmacology   21 août 2023
Publication bias in pharmacogenetics of adverse reaction to antiseizure drugs: An umbrella review and a meta-epidemiological study.
PloS one   30 décembre 2022
Evaluation of pharmacokinetic parameters of critically ill patients and simulation of dosing regimens required by Bayesian Therapeutic Drug Monitoring of fluconazole
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 14–16 June 2022, Lille, France   05 juin 2022
Daptomycin Therapeutic drug monitoring: Evaluation of simplified sampling strategies for Bayesian AUC estimation
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 14–16 June 2022, Lille, France   05 juin 2022
Pharmacocinétique des antirétroviraux au cours de la grossesse : bilan d'un laboratoire de pharmacologie sur la période 2015-2021
Médecine et Maladies Infectieuses Formation   01 juin 2022
Implementation and Comparison of Two Pharmacometric Tools for Model-Based Therapeutic Drug Monitoring and Precision Dosing of Daptomycin.
Pharmaceutics   04 janvier 2022
Association between voriconazole exposure and Sequential Organ Failure Assessment (SOFA) score in critically ill patients.
PloS one   24 novembre 2021
Population pharmacokinetics of daptomycin in patients with bone and joint infection: minimal effect of rifampicin co-administration and confirmation of a sex difference.
The Journal of antimicrobial chemotherapy   08 juillet 2021
Impact of publication bias in the pharmacogenetics of antiepileptic drugs’ adverse reactions: A systematic umbrella review and meta-epidemiological study
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 15–16 June 2021, E‐meeting, France   02 juin 2021
Potential interference of hydroxychloroquine-glucuronide metabolite on therapeutic drug monitoring of hydroxychloroquine using a mass spectrometry detector.
Clinical chemistry and laboratory medicine   12 mai 2021